↓ Skip to main content

HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial

Overview of attention for article published in Journal of Translational Medicine, April 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news
1 news outlet
blogs
1 blog
twitter
1 X user
patent
2 patents

Citations

dimensions_citation
168 Dimensions

Readers on

mendeley
179 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial
Published in
Journal of Translational Medicine, April 2013
DOI 10.1186/1479-5876-11-88
Pubmed ID
Authors

Mariette I E van Poelgeest, Marij J P Welters, Edith M G van Esch, Linda F M Stynenbosch, Gijs Kerpershoek, Els L van Persijn van Meerten, Muriel van den Hende, Margriet J G Löwik, Dorien M A Berends-van der Meer, Lorraine M Fathers, A Rob P M Valentijn, Jaap Oostendorp, Gert Jan Fleuren, Cornelis J M Melief, Gemma G Kenter, Sjoerd H van der Burg

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 179 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 <1%
Germany 1 <1%
South Africa 1 <1%
Unknown 176 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 35 20%
Researcher 31 17%
Student > Master 18 10%
Student > Doctoral Student 15 8%
Student > Bachelor 14 8%
Other 28 16%
Unknown 38 21%
Readers by discipline Count As %
Medicine and Dentistry 45 25%
Immunology and Microbiology 30 17%
Agricultural and Biological Sciences 28 16%
Biochemistry, Genetics and Molecular Biology 18 10%
Pharmacology, Toxicology and Pharmaceutical Science 4 2%
Other 10 6%
Unknown 44 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 21. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 September 2021.
All research outputs
#1,521,939
of 22,830,751 outputs
Outputs from Journal of Translational Medicine
#253
of 3,994 outputs
Outputs of similar age
#12,820
of 199,959 outputs
Outputs of similar age from Journal of Translational Medicine
#5
of 53 outputs
Altmetric has tracked 22,830,751 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,994 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.5. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 199,959 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 53 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.